Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Clinical Biochemistry|June 14, 2014
Measurement of Galectin-3 with the ARCHITECT assay: Clinical validity and cost-effectiveness in patients with heart failureD Gruson, M Mancini, S A Ahn, et al.
Clinical Laboratory|October 19, 2013
Measurement Nt-proBNP circulating concentrations in heart failure patients with a new point-of-care assayThibault Lepoutre, Michel F Rousseau, Sylvie A Ahn, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 25, 2013
Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fractionD Gruson, M Mancini, S A Ahn, et al.
Intensive Care Medicine|November 5, 1997
Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPDG Hilbert, D Gruson, G Gbikpi-Benissan, et al.
Peptides|December 8, 2009
Circulating levels of stress associated peptide Urocortin in heart failure patientsD Gruson, S A Ahn, J M Ketelslegers, et al.
Practical Laboratory Medicine|May 10, 2021
Do fully automated immunoassays for the evaluation of the immune response to SARS-CoV-2 are commutable?A Mairesse, D Gruson, A Scohy, et al.
The European Respiratory Journal|July 10, 1998
Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiencyG Hilbert, D Gruson, L Portel, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectivelyD Gruson, S Pereyre, H Renaudin, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterizedC M Bebear, H Renaudin, A Charron, et al.
Annales De Medecine Interne|January 5, 2001
[Reactive hemaphagocytic syndrome in a patient with midline NK-cell lymphoma]S Seiberras, G Hilbert, D Gruson, et al.
Pageof 6